Regeneron Pharmaceuticals, Inc. is a company in the U.S. stock market and it is a holding in 173 U.S.-traded ETFs. REGN has around 7.4M shares in the U.S. ETF market. The largest ETF holder of REGN is the iShares NASDAQ Biotechnology ETF (IBB), with approximately 1.02M shares. Investors may also find of interest that the ETF with the largest allocation to REGN stock is VanEck Vectors Biotech ETF (BBH), with a portfolio weight of 5.47%. On average, U.S. ETFs allocate 0.59% of REGN to their portfolios.
Additionally, REGN is a favorite stock for Vanilla and Multi-factor ETFs. It is also most likely to belong to Broad-based ETFs. The best-performing ETF in the past 12 months with REGN as a holding is the ProShares UltraPro QQQ (TQQQ), with a return of 38.22%.